DETERMINATION OF THE TARGET VOLUME OF HELA-CELLS TREATED WITH TETRA-CHLOROPLATINATES AND HEXA-CHLOROPLATINATES

被引:3
作者
AKABOSHI, M
KAWAI, K
MAKI, H
AKUTA, K
MIYAHARA, T
EHRLICH, W
机构
[1] KYOTO UNIV,FAC MED,DEPT SURG 1,SAKYO KU,KYOTO 606,JAPAN
[2] ROBERT KOCH INST,W-1000 BERLIN 65,GERMANY
关键词
PLATINUM(II)CHLORIDE; PLATINUM(IV)CHLORIDE; CISPLATIN; HELA CELL; CELL KILLING; TARGET VOLUME;
D O I
10.1080/02772249109357900
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
HeLa S-3 cells were treated with Pt-195m-radiolabeled tetra- and hexa-chloroplatinums (Pt(II) and Pt(IV)) under various conditions, and the relationship between lethal effect and the number of Pt-atoms binding to DNA, RNA and proteins was examined. The mean lethal concentrations for the cells treated with Pt(II) at 37-degrees-C for 1, 2 and 3 h were 163.5, 126.2 and 67.3 muM, while those for Pt(IV) were 78.6, 53.4 and 35.9, respectively. By using identically treated cells, the number of Pt-atoms combined with DNA, RNA and protein molecules were determined after the cell were fractionated using the method of Schneider [ref. 1]. In this way, the D(o) values given as the drug concentration were substituted for the number of Pt-atoms combined with each fraction, then, die target volumes expressed as the reciprocals of D(o) values were calculated for each fraction. The results suggested that DNA and high molecular weight RNAs (except t-RNA), under some limited condition, can be the target molecules for cell killing by both the compounds. The target volumes for DNA were 3.15x10(3), 3.75x10(3) and 5.86x10(3) nucleotides for 1.2 and 3 h Pt(II)-treated cells, while those for Pt(IV) were 4.27x10(3), 4.58x10(3) and 6.37x10(3) nucleotides, respectively. This means that no significant difference between the two platinates can be detected on the efficiency for Pt-atom to kill the cell. Cell killing effects of Pt(IV) was lower than CDDP (see ref. 7) by a factor of 12-16 according to the treatment, but higher than TDDP (see ref. 8) by a factor of 1.4-2.5.
引用
收藏
页码:51 / 60
页数:10
相关论文
共 11 条
[1]   THE NUMBER OF PLATINUM ATOMS BINDING TO DNA, RNA AND PROTEIN MOLECULES OF HELA-CELLS TREATED WITH CISPLATIN AT ITS MEAN LETHAL CONCENTRATION [J].
AKABOSHI, M ;
KAWAI, K ;
MAKI, H ;
AKUTA, K ;
UJENO, Y ;
MIYAHARA, T .
JAPANESE JOURNAL OF CANCER RESEARCH, 1992, 83 (05) :522-526
[2]  
AKABOSHI M, 1987, Annual Reports of the Research Reactor Institute Kyoto University, V20, P150
[3]  
AKABOSHI M, 1992, IN PRESS NUCL MED BI
[4]   CIS-DIAMMINEDICHLOROPLATINUM, VINBLASTINE, AND BLEOMYCIN COMBINATION CHEMOTHERAPY IN DISSEMINATED TESTICULAR CANCER [J].
EINHORN, LH ;
DONOHUE, J .
ANNALS OF INTERNAL MEDICINE, 1977, 87 (03) :293-298
[5]   INHIBITORY EFFECTS OF ANTI-TUMOR PLATINUM COMPOUNDS ON DNA, RNA AND PROTEIN SYNTHESES IN MAMMALIAN CELLS IN-VITRO [J].
HARDER, HC ;
ROSENBERG, B .
INTERNATIONAL JOURNAL OF CANCER, 1970, 6 (02) :207-+
[7]   SYNTHESIS OF PT-195M RADIOLABELED CIS-DIAMMINEDICHLOROPLATINUM(II) OF HIGH CHEMICAL AND RADIOCHEMICAL PURITY USING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
KAWAI, K ;
MAKI, H ;
EHRLICH, W ;
AKABOSHI, M .
JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY-LETTERS, 1989, 136 (01) :67-74
[8]   DRUGS 5 YEARS LATER - CISPLATIN [J].
LOEHRER, PJ ;
EINHORN, LH .
ANNALS OF INTERNAL MEDICINE, 1984, 100 (05) :704-713
[9]  
SCHNEIDER WC, 1946, J BIOL CHEM, V164, P747
[10]  
YONG RC, 1979, CANC CHEMOTHERAPY 19, P340